Maitake (Grifola frondosa) is a large, frond-like mushroom native to the forests of northeastern Japan, North America, and parts of Europe. Known in Japanese as “the dancing mushroom,” it has a centuries-long history of use in traditional East Asian medicine. In recent decades, laboratory and animal research has turned significant attention toward its bioactive compounds, particularly its polysaccharide fractions, in relation to blood sugar regulation and immune function.
What Makes Maitake Biologically Active?
The primary compounds of interest in maitake are its beta-glucan polysaccharides, especially a specific proteoglucan fraction known as D-Fraction. Beta-glucans are long-chain sugars found in the cell walls of fungi that interact with immune receptors in the human gut and blood. Maitake also contains alpha-glucans, ergosterol (a precursor to vitamin D2), and various phenolic antioxidants. Researchers have proposed that these compounds may influence metabolic and immune pathways through several mechanisms, though most evidence to date comes from preclinical models.
Blood Sugar and Metabolic Effects
A notable area of maitake research involves its potential effects on glucose metabolism. Multiple animal studies have examined G. frondosa polysaccharides in diabetic rodent models. One study published in International Journal of Biological Macromolecules found that G. frondosa polysaccharides produced significant hypoglycemic and hypolipidemic effects in mice with diet-induced and chemically-induced diabetes, with the authors noting a parallel modulation of intestinal microflora composition.[1]
A separate line of research has focused on diabetic nephropathy, a common complication of poorly managed blood sugar. Research published in Applied Biochemistry and Biotechnology reported that G. frondosa polysaccharide treatment in a streptozotocin-induced diabetic mouse model improved glucose tolerance and insulin sensitivity while reducing markers of kidney inflammation, with the authors attributing these effects to suppression of the TLR4/NF-kB inflammatory pathway.[2] The authors of that study noted that polysaccharide fractions from G. frondosa may have a protective role in early-stage kidney injury associated with hyperglycemia.
It is important to note that these studies were conducted in animal models. Human clinical trials examining maitake’s effects on blood sugar are limited and have generally been small in scale. Anyone managing diabetes or blood sugar conditions should consult a qualified healthcare provider before adding any mushroom supplement to their regimen.
Immune Modulation and the D-Fraction
The maitake D-Fraction is among the more researched mushroom extracts in the context of immune function and cancer biology. Preclinical research has investigated its effect on various immune cell types, including natural killer cells and macrophages, as well as its potential to inhibit tumor cell activity.
Research published in Oncotarget examined the effects of maitake D-Fraction on triple-negative breast cancer cells in laboratory conditions, reporting both immunostimulatory and direct antitumoral effects.[3] This type of cancer lacks targeted therapies, making research into novel compounds an active area of interest. The study’s authors described D-Fraction as capable of exerting effects independent of immune modulation, though they emphasized that further research is needed to understand the mechanisms fully.
More recently, structural analysis of G. frondosa glucan fractions has revealed additional complexity in how these polysaccharides interact with the immune system. A 2026 study in Carbohydrate Polymers characterized an alpha-glucan from maitake and documented its antitumor activity via immune modulation pathways in preclinical settings.[4] This work adds to a growing body of evidence that maitake contains structurally diverse polysaccharides, each potentially contributing to different biological activities.
Antioxidant and Anti-Inflammatory Properties
Beyond blood sugar and immunity, research suggests maitake may support antioxidant activity through its phenolic content. Oxidative stress plays a contributing role in many chronic conditions, and reducing it is a shared focus across functional mushroom research. Maitake’s ergosterol content may also contribute to vitamin D status when the mushroom is exposed to UV light, similar to other species such as shiitake, though the bioavailability of this form of vitamin D in humans requires further study.
How Maitake Compares to Other Functional Mushrooms
Maitake occupies a somewhat distinct niche among functional mushrooms due to its metabolic research profile. While lion’s mane is associated primarily with neurotrophic effects and reishi with broad immune modulation and stress adaptation, maitake’s most-studied properties cluster around glucose metabolism and beta-glucan-mediated immune signaling. For those interested in how mushroom species compare across categories including gut and immune health, our overview of the best mushrooms for gut health covers complementary evidence across multiple species.
Supplement Considerations
Maitake is available as dried powder, capsules, and liquid extracts. D-Fraction is typically sold as a concentrated liquid extract standardized to a specific proteoglucan content. When evaluating any maitake supplement, the beta-glucan percentage listed on the label offers insight into potency, though standardization practices vary across manufacturers. Hot-water extraction is commonly used because beta-glucans are water-soluble and more bioavailable in this form compared to raw dried powder.
As with other functional mushroom supplements, maitake should be treated as a complementary addition to an overall wellness approach rather than a standalone intervention. Given the preliminary nature of blood sugar research, individuals on glucose-lowering medications should consult a physician, as additive effects are theoretically possible.
References
- 1. Guo WL et al. Hypoglycemic and hypolipidemic activities of Grifola frondosa polysaccharides and their relationships with the modulation of intestinal microflora in diabetic mice. Int J Biol Macromol. 2020;153:1231-1240. PMID 31759027
- 2. Jiang T et al. Grifola frondosa Polysaccharide Ameliorates Early Diabetic Nephropathy by Suppressing the TLR4/NF-kB Pathway. Appl Biochem Biotechnol. 2022;194(9):4093-4104. PMID 35616773
- 3. Alonso EN et al. Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells. Oncotarget. 2018;9(34):23396-23412. PMID 29805742
- 4. Tian HX et al. Structural characterization and antitumor activity via immune modulation of an alpha-glucan from Grifola frondosa. Carbohydr Polym. 2026;382:125254. PMID 42002344
Disclaimer: The information on this page is intended for educational purposes only and does not constitute medical advice. Grifola frondosa supplements have not been approved by the FDA to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before beginning any new supplement, especially if you are pregnant, nursing, taking prescription medications, or managing a medical condition.
